- Trials with a EudraCT protocol (138)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
138 result(s) found for: Bisphosphonates.
Displaying page 1 of 7.
EudraCT Number: 2021-005401-28 | Sponsor Protocol Number: AOI2021ME_PICKERING | Start Date*: 2022-01-26 |
Sponsor Name:University Hospital of Clermont-Ferrand | ||
Full Title: Effects of the combination of magnesium bisphosphonates versus bisphosphonates alone on bone remodeling: Randomized pilot clinical trial | ||
Medical condition: postmenopausal osteoporosis | ||
Disease: | ||
Population Age: Elderly | Gender: Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004529-57 | Sponsor Protocol Number: 06/AM/108 | Start Date*: 2008-09-08 |
Sponsor Name:Greenpark Healthcare Trust | ||
Full Title: Vascular Pleiotrophic Effects of Bisphosphonates in Post Menopausal Women with Osteoporosis: Cellular Mechanisms and Functional Consequences | ||
Medical condition: osteoporosis cardiovascular disease | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003131-28 | Sponsor Protocol Number: IP-2012-01 | Start Date*: 2013-01-22 | |||||||||||
Sponsor Name:Instituto Palacios | |||||||||||||
Full Title: Switching from Oral Bisphosphonates to Bazedoxifene once a day to evaluate effects on BMD in Postmenopausal Women. | |||||||||||||
Medical condition: Ambulatory postmenopausal women with low BMD in general good health | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000290-31 | Sponsor Protocol Number: 2011.1.42 | Start Date*: 2011-12-27 |
Sponsor Name:Evangelisches Krankenhaus Lutherhaus gGmbH | ||
Full Title: Comparison of the effect of an ongoing treatment with alendronate or a drug holiday on the fracture risk in osteoporotic patients with a bisphosphonate long term therapy | ||
Medical condition: Osteoporosis (DXA-T-Score <-2,0 at lumbar spine, total hip or femur neck OR previous low trauma vertebral fractures) at high fracture risk | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-003606-14 | Sponsor Protocol Number: SCH-2013 | Start Date*: 2017-01-31 | |||||||||||
Sponsor Name:Sheffield Children's NHS Foundation Trust | |||||||||||||
Full Title: Do bisphosphonates alter the skeletal response to mechanical stimulation in children with osteogenesis imperfecta? | |||||||||||||
Medical condition: Osteogenesis Imperfecta | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017369-47 | Sponsor Protocol Number: 09/CMC/4659E | Start Date*: 2010-11-30 |
Sponsor Name:Research and Development Office Cardiff and Vale NHS Trust [...] | ||
Full Title: An in-vitro observational pilot study of the role of gamma delta T cells in the acute phase reaction to intravenous bisphosphonate; in blood samples donated by patients receiving intravenous bispho... | ||
Medical condition: Osteoporosis and Paget's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-000511-25 | Sponsor Protocol Number: 20040114 | Start Date*: 2004-10-08 |
Sponsor Name:Amgen Inc | ||
Full Title: A Randomized, Open Label, Active Controlled Study of AMG 162 in Subjects with Advanced Cancer Currently Being Treated with Intravenous Bisphosphonates | ||
Medical condition: Bone metastases of solid tumors (except lung) or multiple myeloma bone disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000900-17 | Sponsor Protocol Number: ejude001 | Start Date*: 2007-02-13 |
Sponsor Name:The University of Manchester [...] | ||
Full Title: A randomised double-blind placebo controlled trial of the oral bisphosphonate, Alendronate, plus intravenous pamidronate, in active diabetic Charcot neuroarthropathy (CN). | ||
Medical condition: Charcot neuroarthropathy Code: E10.6 Insulin + M14.6 Code: E11.6 Insulin + M14.6 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-001059-63 | Sponsor Protocol Number: 2015.009 | Start Date*: 2015-09-23 | |||||||||||
Sponsor Name:Aalborg University | |||||||||||||
Full Title: BONATHIAD - Bone Association with Thiazide Diuretics. | |||||||||||||
Medical condition: The effect of bendroflumethiazide with potassium supplement when used as an adjuvant to oral bisphosphonates in the treatment of newly diagnosed osteoporosis among post-menopausal women above 50 ye... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003138-16 | Sponsor Protocol Number: Ed001 | Start Date*: 2005-08-26 | |||||||||||
Sponsor Name:R+ D department, Hull and East Yorkshire NHS Hospital Trust | |||||||||||||
Full Title: A clinical observational study to assess the effectiveness of Strontium Ranelate on bone protection in osteoporotic patients pre-treated with bisphosphonates. | |||||||||||||
Medical condition: Postmenopausal Osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000988-28 | Sponsor Protocol Number: 19403 | Start Date*: 2011-08-16 | |||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||
Full Title: Fractures and Bisphosphonates: A double-blind, randomised controlled trial on the effect of alendronic acid on healing and clinical outcomes of wrist fractures | |||||||||||||
Medical condition: Fracture healing | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002693-66 | Sponsor Protocol Number: 0822-018 | Start Date*: 2007-11-13 | |||||||||||
Sponsor Name:MERCK SHARP & DOHME CORP. | |||||||||||||
Full Title: A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of MK-0822 to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D an... | |||||||||||||
Medical condition: Postmenopausal Osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: LT (Completed) DK (Completed) CZ (Prematurely Ended) PL (Prematurely Ended) GB (Prematurely Ended) DE (Completed) FR (Prematurely Ended) BE (Prematurely Ended) LV (Completed) EE (Completed) IT (Completed) ES (Completed) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-009756-21 | Sponsor Protocol Number: 20070315 | Start Date*: 2009-10-26 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Single-arm, Multicenter, Proof-of-concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonates. | |||||||||||||
Medical condition: Hypercalcemia of malignancy (HCM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003658-13 | Sponsor Protocol Number: EWING2008 | Start Date*: 2009-03-19 | ||||||||||||||||||||||||||
Sponsor Name:Universitaetsklinikum Muenster | ||||||||||||||||||||||||||||
Full Title: EWING 2008 | ||||||||||||||||||||||||||||
Medical condition: Ewing sarcoma Malignant peripheral neuroectodermal tumour Askin tumour Atypical Ewing sarcoma | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) AT (Completed) BE (Completed) NL (Completed) SE (Completed) HU (Completed) FI (Completed) LT (Completed) PL (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-005249-21 | Sponsor Protocol Number: 1239.3 | Start Date*: 2006-02-16 |
Sponsor Name:Boehringer Ingelheim Ltd. | ||
Full Title: A multi-centre 3-arm randomized phase II trial of BIBF 1120 versus BIBW 2992 versus sequential administration of BIBF 1120 and BIBW 2992 in patients with hormone-resistant prostate cancer | ||
Medical condition: Chemo-naive hormone refractory prostate cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005255-18 | Sponsor Protocol Number: 1216.19 | Start Date*: 2006-07-03 |
Sponsor Name:Boehringer Ingelheim UK Ltd | ||
Full Title: A single arm phase II study to investigate the efficacy, safety and pharmacokinetics of a single dose of 200 mg of i.v. BI 2536, administered once every 3 weeks in patients with advanced metastatic... | ||
Medical condition: Advanced Metastatic Hormone Refractory Prostate Cancer | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001698-41 | Sponsor Protocol Number: P140909 | Start Date*: 2016-02-12 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Non-inferiority trial of three cycles of zoledronic acid versus percutaneous thermal ablation in osteoid osteoma | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001068-27 | Sponsor Protocol Number: 2020-001068-27 | Start Date*: 2020-12-01 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Pamidronate for pain in adult chronic nonbacterial osteitis (PAM-CNO): a randomized, double-blind, placebo-controlled trial | ||
Medical condition: Chronic nonbacterial osteitis (CNO) in adults | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2010-018904-94 | Sponsor Protocol Number: 2010-018904-94 | Start Date*: 2010-05-31 | |||||||||||
Sponsor Name:FONDAZIONE SALVATORE MAUGERI - CLINICA DEL LAVORO E DELLA RIABILITAZIONE | |||||||||||||
Full Title: EFFICACY AND SAFETY OF INTRAMUSCULAR NERIDRONATE IN OSTEOPOROTIC PATIENTS AFFECTED BY PARKINSON'S DISEASE | |||||||||||||
Medical condition: Osteoporosis in patients affected by Parkinson's disaease at the stages 1-2-3-4 following Hoehn and Yahr criteria | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002965-19 | Sponsor Protocol Number: 1 | Start Date*: 2005-03-14 |
Sponsor Name:Orthopaedic department, Karolinska Institutet, Danderyd's Hospital | ||
Full Title: Can risedronate prevent periprosthetic bone loss after hip arthroplasty? A randomized, double-blind, placebo-controlled trial | ||
Medical condition: Periprosthetic bone loss after total hip arthroplasty (THA) is the main factor in limiting the longevity of implants used för treatment of osteoarthritis. Bone loss leads to implant destabilization... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
